Curriculum vitae peter J. Quesenberry, M. D

Quesenberry PJ: The effect of lithium on megakaryocytic proliferation and differentiation in murine Dexter culture. Blood 65:122a, 1984.
A58. Quesenberry PJ, Song Z, Shadduck R, Waheed A: Murine marrow stromal cell production of a CSF-1 dependent growth factor. (Presented at the UCLA Symposium in Park City, Utah, February 1985.)
A59. Alberico TA, Ihle JN, McGrath HE, and Quesenberry PJ: Interleukin-3 (IL-3) dependent stem cells and production of growth factors in Dexter cultures. Clin Res 33: 332A, 1985.
A60. Quesenberry PJ, Landreth K, Witte P, Shadduck R, Waheed A, Kleeman E, McGrath E, Baber G: Pre-B cell inducing and hemopoietic synergistic activity produced by a murine marrow adherent cell line. Blood 66:157a, 1985.
A61. McGrath E, Shadduck R, Waheed A, Quesenberry PJ: Lithium stimulation of growth factor production from murine marrow adherent cells. Blood 66:157a, 1985.
A62. Landreth KS, Beare MH, Quesenberry PJ, Kincade PW: Detection of pre-B cell differentiation activity in supernatants from a bone marrow stromal cell line. Fed Proc FASEB 45:1097, 1986.
A63. Quesenberry PJ, He Y, Hewlett E, Baber G, McGrath E: The effect of pertussis toxin on hemopoietic growth factor-induced proliferation. (Presented at the 2nd International Symposium on Cellular Endocrinology, Lake Placid, New York, Sept. 8-11, 1986.)
A64. Quesenberry PJ, Alberico T, Liang C, Ihle J, McGrath H, Shadduck R, Waheed A: The role of granulocyte-macrophage colony-stimulating factor (GM-CSF) in long-term murine marrow Dexter cultures. Blood 68:177a, 1986.
A65. Robinson B, McGrath H, Quesenberry PJ: Megakaryocyte stimulating and interleukin-3 (IL-3) potentiating effects of recombinant granulocyte macrophage colony stimulating factor (GM-CSF). Blood 68:178a, 1986.
A66. Woodward T, Isakson P, Baber G, McGrath H, Quesenberry PJ: Production of pre-B and B cell growth factors by a marrow adherent cell line (TC-1). Blood 68:102a, 1986.
A67. He Y, Hewlett E, Baber G, McGrath HE, Quesenberry PJ: Mechanisms of action of interleukin-3 and colony stimulating factor-1 stimulation of murine hemopoietic cells. Blood 68:166a, 1986.
A68. Colon-Otero G, Quesenberry PJ, McGrath HE: The inhibition of interleukin-3 induced cell proliferation by ADP-ribosylation inhibitors. Exp Hematol 14:546a, 1986.
A69. He Y, Hewlett, E, Baber G, McGrath HE, Quesenberry PJ: The effect of pertussis toxin on interleukin-3 and colony stimulating factor-1 stimulated cell growth. Exp Hematol 14:547a, 1986.
A70. Colon-Otero G, Sando J, Sims JL, McGrath H, Quesenberry PJ: Inhibition of hematopoietic growth factor induced proliferation by ADP-ribosylation inhibitors. Blood 68:140a, 1986.
A71. Landreth KS, Beare MH, Quesenberry PJ, Kincade PW: Detection of pre-B cell differentiation activity in supernatants from a bone marrow stromal cell line. Fed Proc FASEB 45:1097, 1986.
A72. Tabbara IA, Quesenberry PJ: Spinal cord compression secondary to metastatic neoplasm. (Presented at the 24th Annual Meeting of the Virginia Society of Hematology and Oncology, Virginia Beach, Virginia, June 1986.
A73. McNiece IK, Woodward TA, Quesenberry PJ: Studies on hemo­lympho­poietic growth factor-1 (HLGF-1) which stimulates early myeloid and lymphoid progenitor cells. Exp Hematol 15:592a, 1987.
A74. He Y, Hewlett E, McGrath HE, Quesenberry PJ: Differential response of FDC-Pl and 32DCl-23 cell lines to pertussis toxin and PMA. Exp Hematol 15:600a, 1987.
A75. McNiece I, Stewart M, Deacon D, Quesenberry PJ: Synergistic interactions between hematopoietic factors as detected by in vitro murine bone marrow colony formation. (Presented at the 4th Terry Fox Cancer Conference, "Stem Cells and Autologous Bone Marrow Transplantation." Vancouver, British Columbia, September 1987).
A76. McNiece IK, Woodward T, Baber G, Hudson D, Quesenberry PJ: Purification of a growth factor (HLGF-1) which stimulates primitive hematopoietic progenitor cells. American Cancer Society, 7th Annual Seminar of Cancer Research, Charlottesville, Virginia, March 1987).
A77. McNiece IK, Stewart FM, Quesenberry PJ: Synergistic interactions of hematopoietic growth factors on murine and human bone marrow: evidence of a human HPP-CFC. Blood 70(5): Suppl 1, p 179a, 1987.
A78. McNiece IK, Deacon DM, Baber GB, Quesenberry PJ: Studies on hematopoietic growth factors produced by the stromal derived cell line TC-1: purification of HLGF-1 to apparent homogeneity. Blood 70(5): Suppl 1, p 179a, 1987.
A79. Simpson L, Newberg M, Lynch K, McNiece I, Quesenberry PJ, Isakson P: Cytokine requirements for growth and differentiation of activated B cells. FASEB J 2(4):A876, 1987.
A80. McNiece IK, Quesenberry PJ: Human IL-3 stimulates primitive human bone marrow progenitor cells. (Presented to the Leukemia Society of America meeting, New Orleans, Louisiana, March 16-19, 1988).
A81. Quesenberry PJ, McNiece I, McGrath E, Souza L, Baber G: Multilineage stimulating effects of recombinant human granulocyte colony stimulating factor (rhG-CSF). Exp Hematol 16:554a, 1988.
A82. Niskanen E, Quesenberry PJ, McNiece I; Relationship between CFU-blast, HPP-CFC and CFU-D. Exp Hematol 16:538 (abstract #311), 1988.
A83. McNiece IK, Andrews RG, Stewart FM, Quesenberry PJ: Human bone marrow progenitor cell populations. Exp Hematol 16:550 (abstract #359), 1988.
A84. Temeles DS, Quesenberry PJ: Induction of marrow macrophage growth factor production with lectin. Exp Hematol 16:555 (abstract #380), 1988.
A85. Ruland LJ III, Boman TE, Quesenberry PJ, Balian G: Bone marrow macrophages synthesize a 17KD collagenous polypeptide. (Presented at 4th International Congress of Cell Biology, August 1988).
A86. McNiece IK, Andrews RG, Stewart FM, Quesenberry PJ: Synergistic interactions of human growth factors in in vitro cultures of human bone marrow cells. Blood 72:125a (abstract #410), 1988.
A87. McNiece IK, Kriegler AB, Quesenberry PJ: Studies on the myeloid synergistic factor from 5637: comparison to interleukin-1 alpha. Blood 72:125a (abstract #411), 1988.
A88. McGrath HE, Quesenberry PJ: Growth factor mRNA production by bone marrow stromal cells following irradiation and lectin exposure. Blood 72:125a (abstract #409), 1988.
A89. Temeles DS, Quesenberry PJ: Lectin induction of G-CSF production in a population of purified murine bone marrow macrophages. Blood 72:136a (abstract $453), 1988.
A90. Stewart FM, Crittenden RB, Quesenberry PJ: Long-term chimerism in normal nonirradiated mice transplanted with large numbers of marrow cells. Exp Hematol 17:543 (abstract #161), 1989.
A91. Niskanen E, McNiece IK, High VD, Quesenberry PJ: In vitro growth potential of cells derived from in vivo diffusion chamber cultures. Exp Hematol 17:576 (abstract #194), 1989.
A92. Robinson BE, Gear ARL, Quesenberry PJ: The effect of hemato­poietic growth factors on platelet aggregation. Blood 74:331a (abstract #1254), 1989.
A93. McGrath HE, Robinson BE, McNiece IK, Deacon DH, Clark S, Quesenberry PJ: Interleukin-6 and multifactor stimulation of murine megakaryocyte colony formation. Blood 74:154a (abstract #571), 1989.
A94. Quesenberry PJ, Ennis JD, Muench J: Origin of cultured Dexter murine marrow stromal cells. Blood 4:14a (abstract #38), 1989.
A95. Temeles DS, McGrath HE, Shadduck RK, Quesenberry PJ: Growth factor production by murine Dexter stromal cells. Blood 74:116a (abstract #429), 1989.
A96. Temeles DS, Stewart FM, McNiece IK, Meyer DL, Quesenberry PJ: 5-Fluorouracil modulation of human bone marrow. Blood 74:112a (abstract #415), 1989.
A97. Quesenberry PJ, Deacon DH, Zhao L: Murine high proliferative potential colony forming cells (HPP-CFC): Effect of phorbol myristate acetate (PMA). Blood 74:72a (abstract #261), 1989.
A98. Stewart FM, Crittenden RB, Quesenberry PJ: Long-term chimerism in normal nonirradiated mice transplanted with large numbers of marrow cells. Blood 74:423a (abstract #1623), 1989.
A99. Blue BA, Ruland LJ, Learish RD, Quesenberry PJ, Balian G: Type I collagen homotrimer synthesized by a murine bone marrow cell line with osteoblast-like characteristics. (Presented at the 16th Annual Meeting of the Orthopaedic Research Society, New Orleans, Louisiana, February, 1990).
A100. Quesenberry PJ, Temeles DS, McGrath HE, Crittenden R: Growth factor production by murine adherent cell populations. Exp Hematol 18:566 (abstract #68), 1990.
A101. McGrath HE, Kister VK, Quesenberry PJ: Lithium induction of murine marrow stromal cell growth factor mRNA. Exp Hematol 18:566 (abstract #67), 1990.
A102. McNiece IK, Temeles DS, Fuller KH, Quesenberry PJ: Further characterization of human high proliferative potential colony forming cells. Exp Hematol 18:552 (abstract #15), 1990.
A103. Lowry PA, Temeles DS, Meyer DL, Quesenberry PJ: Multi-factor stimulation of murine HPP-CFC in serum-replete and serum-free conditions. Blood 76:104a (abstract #407), 1990.
A104. Reddy GPV, Deacon DH, Reed WC, Quesenberry PJ: Regulatory role of a 68kDa calmodulin-binding protein in IL-3, GM-CSF and G-CSF stimulation of factor dependent cell lines. Blood 76:162a (abstract #638), 1990.
A105. Quesenberry PJ, McGrath HE, Kister K, Kittler E, Crittenden R, Temeles D: Constitutive production of multiple hemopoietic growth factors by murine Dexter stroma. Blood 76:161a (abstract #635), 1990.
A106. Quesenberry PJ, Balian G: Collagenase-sensitive 17K protein from Dexter culture stroma is carbohydrate binding protein-35. Blood 76:190a (abstract #752), 1990.
A107. Reddy GPV, Reed WC, Deacon D, Quesenberry PJ: Signaling function of a 68 kDa calmodulin-binding protein in hemopoietic cells. Exp Hematol 19:505 (abstract #183), 1991.
A108. Lowry P, Zsebo KM, Deacon D, Fullen A, Quesenberry PJ: Multifactor stimulation of murine HPP-CFC. Exp Hematol 19:584 (abstract #481), 1991 (presented at Presidential Symposium).
A109. Ramakrishna P, Quesenberry PJ, Balian G: A carbohydrate binding protein (CBP-35) is regulated by colony stimulating factor-1. Exp Hematol 20:108 (abstract #12), 1991.
A110. Lowry P, Ksebo KM, McGrath HE, Deacon DH, Quesenberry PJ: The high proliferative potential megakaryocyte mixed (HPP-meg-mix) colony forming cell, a newly described murine hematopoietic progenitor. Blood 78:133a, 1991.
A111. Kittler ELW, Crittenden RB, McGrath H, Turner BL, Kister VK, Quesenberry PJ: Support of factor dependent cells by explant bone marrow stroma and stromal cell subpopulations is inhibited by antibodies to cytokines. Blood 78:20a, 1991.
A112. McGrath HE, Kister VK, Quesenberry PJ: Lithium induction of growth factors from murine Dexter culture. Blood 78:293a, 1991.
A113. Srikumar K, Hussaini I, Deacon D, Kumar S, Gonias S, Quesenberry PJ: A novel high molecular weight CSF-1 from a murine stromal cell line (TC-1) that stimulates high proliferative potential colony forming cells (HPP-CFC). Blood 78:20a, 1991.
A114. Reddy GPV, Reed WC, Deacon D, Quesenberry PJ: Further studies on the regulatory role of 68 kDa calmodulin-binding protein in cytokine-mediated proliferation of hemopoietic cells. Blood 78:156a, 1991.
A115. Crittenden R, Stewart FM, Williams M, Quesenberry PJ: "Competitive" marrow transplantation: A murine model. Blood 78:400a, 1991.
A116. Stewart FM, Temeles DS, Thraves T, Grosh WW, Tabbara IA, Quesenberry PJ: Improved platelet recovery following 5FU modulation of human bone marrow. Blood 78:234a, 1991.
A117. Lowry PA, Zsebo KM, Deacon DD, Rogers P, Quesenberry PJ: rrSCF as a possible anchor factor in the stimulation of murine HPP-CFC. Blood 78:258a, 1991.
A118. Lowry PA, McGrath HE, Deacon DD, Quesenberry PJ: Identification of a new hematopoietic stem cell, high proliferative potential megakaryocyte-mixed (HPP-Meg-Mix) colony-forming cell. Intl J Cell Cloning 9:366, 1991.
A119. Quesenberry PJ, Kittler ELW, McGrath HE, Temeles DS, Crittenden RB: Stromal-derived growth factor control of hemopoiesis. Intl J Cell Cloning 9:406, 1991.
A120. Deacon DD, Lowry PA, Quesenberry PJ: Phorbol esters produce proliferative synergies with G-CSF, GM-CSF, IL-HE, Kister VK, Quesenberry PJ (intro by M. Stewart): Mechanisms of lithium's induction of cytokine message from murine Dexter culture. Exp Hematol 20:218a, 1992.
A123. Srikumar K, Lowry P, Quesenberry PJ: A high molecular weight CSF-1 with unique HPP-CFC stimulatory activity. Exp Hematol 20:378a, 1992.
A124. Crittenden RB, Kittler ELW, Kumar S, Quesenberry PJ: In situ hybridization detects IL-3 mRNA in a subpopulation of murine Dexter stroma. Exp Hematol 20:393a, 1992.
A125. Kittler ELW, Turner BL, Crittenden RB, Quesenberry PJ: Interleukin-3 (IL-3) is a possible paracrine and/or autocrine regulatory mechanisms in murine bone marrow cultures. Exp Hematol 20:399a, 1992.
A126. Kister VK, McGrath HE, Quesenberry PJ: Discordant horse serum effects on murine Dexter culture hemopoiesis and stromal cytokine production. Exp Hematol 20:415a, 1992.
A127. Crittenden RB, Kittler ELW, Quesenberry PJ: Detection of IL-3 mRNA in murine Dexter stromal cells by in situ hybridization. Blood 80(10):87a, 1992.
A128. Kittler ELW, Crittenden RB, Turner BL, Quesenberry PJ: An interleukin-3 (IL-3) autocrine/paracrine regulatory mechanism for the support of hematopoietic cells by murine bone marrow cultures. Blood 80(10):87a, 1992.
A129. Lowry PA, Fullen A, Whitefield P, Deacon D, Quesenberry PJ: Hematopoietic cell proliferation and differentiation-II. Blood 80(10):171a, 1992.
A130. Lowry PA, Whitefield P, Deacon D, Quesenberry PJ: Growth factors direct proliferation of murine HPP-CFC in a temporal hierarchy. Blood 80(10):171a, 1992.
A131. Kister VK, McGrath HE, Quesenberry PJ: Murine Dexter culture hematopoiesis and stromal cytokine production show discordant effects of different lots of horse serum. Blood 80(10):401a, 1992.
A132. Wheby MS, Jones-Garrison S, Quesenberry PJ, Grosh WW, Stewart FM: Sequential growth factor assays following bone marrow transplantation (BMT). Blood 80(10):422a, 1992.
A133. Crittenden R, Rao S, Quesenberry PJ: Repetitive marrow transplantation: A model for autologous gene therapy. Exp Hematol. 21(8):30a, 1993.
A134. Lim M, Murray J, Recht L, Haregewoin A, Smyczynski M, Romanik E, FitzGerald TJ, Quesenberry PJ: Radiation survival in the relationship of micronuclei formation in a C6 glioma cell. ISPO. 103a, 1993.
A135. Ramshaw HS, Crittenden R, Blomberg M, Rao S, Peters SO, Kittler EL, Quesenberry PJ: Effect of cell cycle on the engraftment of murine bone marrow into unmyeloablated hosts. Exp Hematol 22(8):823 (abstract #548), 1994.
A136. Cooper C, Brady G, Iscove N, Quesenberry PJ: Differential expression of ID-type HLH negative transcriptional regulators during growth and development in the hematopoietic system. Exp Hematol 22(8):722 (abstract #167), 1994.
A137. Reddy GPV, McGrath C, Deacon DH, Quesenberry PJ: Enhanced effect of SCF on Il-3-dependent induction of 68 kDa calmodulin-binding protein and thymidine kinase in NFS-60 cells. Exp Hematol 22(8):722 (abstract #168), 1994.
A138. Rao SS, Crittenden R, Peters SO, Ramshaw HS, Kittler ELW, Tiarks C, Reilly J, Blomberg M, Lowry P, Hulspas R, Quesenberry PJ: Augmentation of engraftment into non-myeloablated hosts with repetitive transplant and increasing cell doses: A model for gene therapy. Exp Hematol 22(8):728 (abstract #189), 1994.
A139. Kittler ELW, Turner BL, Quesenberry PJ: Autocrine interleukin-3 (Il-3) mRNA induction and apoptosis are both density-dependent phenomena of the Il-3 dependent cell line 32D. Exp Hematol 22(8):743 (abstract #245), 1994.
A140. Lowry PA, Schulz LD, Greinier D, Tiarks CY, Rao SS, Leif J, Ramshaw H, Paquin L, Quesenberry PJ: Human hematopoietic progenitor engraftment into Nod-scid/scid mice does not require cytokine support. Exp Hematol 22(8):802 (abstract #469), 1994.
A141. Peters, SO, Kittler ELW, Ramshaw HS, Reilly J, Tiarks CY, Blomberg ME, Hulspas R, Quesenberry PJ: Cytokine incubation of murine marrow cells impairs repopulating capacity in nomal (non-myeloablated) hosts. Exp Hematol 22(8):823 (abstract #547), 1994.
A142. Cooper C, Brady G, Iscove N, Quesenberry PJ: Differential expression ID-type HLH negative transcriptional regulators during growth and development in the hematopoietic system. Blood 84(10):17a (abstract #55), 1994.
A143. Coetzee S, Ogilvie V, Brunner G, Quarto N, Rifkin D, Quesenberry PJ, Wilson EL: Basic fibroblast growth factor (bFGF) transfected stromal cells support survival of MO7E cells. Blood 84(10):279a (abstract #1101), 1994.
A144. Becker PS, Li Z, Quesenberry PJ: Cytokine regulation of cell adhesion receptor expression in hematopoietic cells. Blood 84(10):280a (abstract #1104), 1994.
A145. Kittler ELW, Crittenden RB, Debatis M, Ramshaw HR, Peters SO, Tiarks CY, Quesenberry PJ: Enhancement of retroviral integration by cytokine stimulation impairs engraftment of bone marrow cells into non-myeloablated hosts. Blood 84(10):344a (abstract #1360), 1994.
A146. Kittler ELW, Rao SS, Ramshaw HS, Reilly J, Tiarks CY, Blomberg ME, Quesenberry PJ: Incubation of murine marrow in cytokines leads to cell cycle activation and to impaired repopulating ability in non-myeloablated hosts. Blood 84(10):345a (abstract #1366), 1994.
A147. Blomberg M, Rao SS, Reilly J, Tiarks C, Ramshaw HS, Peters SO, Kittler ELW, Quesenberry PJ: Repetitive bone marrow transplant in non-myeloablated recipients. Blood 84(10):345a (abstract #1367), 1994.
A148. Lowry PA, Shultz LD, Greiner D, Tiarks CY, Rao SS, Ramshaw H, Quesenberry PJ: Multiple immune defects of the NOD/LtSz-scid/scid mouse facilitate human hematopoietic engraftment. Blood 84(10):346a (abstract #1369), 1994.
A149. Rao SS, Crittenden R, Peters SO, Ramshaw HS, Kittler ELW, Tiarks C, Reilly J, Blomberg M, Quesenberry PJ: Repetitive transplantation and increasing cell doses augments engraftment in non-myeloablated hosts: A model for gene therapy. Blood 84(10):355a (abstract #1406), 1994.
A150. Ramshaw JS, Rao SS, Blomberg ME, Peters SO, Crittenden RB, Quesenberry PJ: Cell cycle status of engrafting bone marrow into unmyeloablated hosts. Blood 84(10):730a (abstract #2906), 1994.
A151. Hulspas R, Tiarks C, Quesenberry PJ: Comparison of growth factor receptor mRNA expression in different hemopoietic stem cell populations. Exp Hematol 23(8):812 (abstract #244), 1995.
A152. Rothenberger S, Martin J, McQuain C, Bachmann E, Quesenberry PJ, Knecht H: Naturally occuring deletion variants within the growth transforming domain of the LMP1 oncogene of EBV influence the LMP1 oncogene expression and colony formation. Exp Hematol 23(8):789 (abstract #171), 1995.
A153. Ramshaw HS, Dooner M, Peters SO, Rao SS, Quesenberry PJ: High levels of engraftment of male BALB/c bone marrow into normal female BALB/c hosts with a single infusion of cells. Exp Hematol 23(8):807 (abstract #227), 1995.
A154. Rao SS, Peters SO, Crittenden RB, Ramshaw HS, Quesenberry PJ: Linear relationship of marrow engraftment to cell dose in the normal host transplantational model. Exp Hematol 23(8):808 (abstract #234), 1995.
A155. Reddy GPV, Ramshaw H, Tiarks C, Pang L, Quesenberry PJ: Approaches to synchronize murine bone marrow cells at various stages in cell cycle. Exp Hematol 23(8):813 (abstract #248), 1995.
A156. Peters SO, Kittler ELW, Ramshaw JS, Quesenberry PJ: In vitro expanded murine hematpoietic progenitor cells entering active cell cycling acquire an engraftment defect in irradiated hosts. Exp Hematol 23(8): 785 (abstract #157), 1995.
A157. Becker PS, Li Z, Tiarks C, Ramshaw HS, Quesenberry PJ: Murine hematpoietic stem cells exhibit a complex pattern of cell adhesion receptor expression. Blood 86(10):111a (abstract #430), 1995.
A158. Peters SO, Kittler ELW, Stewart FM, Quesenberry PJ: Conditioning non-irradiated BALB/c mice with stem cell factor to improve engraftment of transduced donor cells for gene therapy. Blood 86(10):113a (abstract #438), 1995.
A159. Kittler ELW, Peters SO, Debatis ME, Stewart FM, Quesenberry PJ: Hematpoietic stem cell engraftment is superior in normal hosts as compared to myeloablated hosts. Blood 86(10):113a (abstract #441), 1995.
A160. Nilsson SK, Hulspas R, Weier HU, Quesenberry PJ: In vivo detection of individual transplanted bone marrow cells, using FISH on sections of paraffin embedded murine femurs: Blood 86(10):226a (abstract #891), 1995.
A161. Ramshaw HS, Dooner M, Quesenberry PJ: 5-fluorouracil treated bone marrow shows impaired engraftment in lethally iradiated BALB/c hosts. Blood 86(10):226a (abstract #892), 1995.
A162. Knecht H, McQuain C, Rothenberger, S, Drexler HG, Martin J, Bachmann E, Kittler ELW, Odermatt BF, Quesenberry PJ: Expression of the LMP1 oncoprotein in the Epstein-Barr virus negative Hodgkin's disease cell line L-428 is associated with Reed-Sternberg cell morphology. Blood 86(10):273a (abstract #1078), 1995.
A163. Hulspas R, Tiarks C, Romanik E, Reilly J, Salmonsen R, Recht L, Quesenberry PJ: CSF-1 and EGF synergize the proliferation of murine embryonic neural progenitor cells in vitro. Blood 86(10): 309a (abstract #1223), 1995.
A164. Ogilvie V, Coetzee S, Rifkin D, Quesenberry PJ, Wilson EL: Basic fibroblast growth factor (bFGF) transfected stromal cells promote the growth of dami leukemic cells. Blood 311a (abstract #1229), 1995.
A165. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Diminished potential of in vitro expanded hematopoietic progenitors in active cell cycle for long-term repopulation of irradiated hosts. Blood 86(10):462a (abstract #1834), 1995.
A166. Peters SO, Kittler ELW, Stewart FM, Ramshaw HS, Quesenberry PJ: Culture of murine marrow with subliminal amounts of stem cell factor promotes survival of hematopoietic progenitors in cellcycle dormancy. Blood 86(10):492a (abstract #1959), 1995.
A167. Knecht H, Raphael M, McQuain, Rothenberger S, Pihan G, Bachmann E, Ryan S, Kittler ELW, Quesenberry PJ, Schlaifer D, Woda BA, Brousset P: Deletion variants within the NF-B activation domain of the LMP1 oncogene of epstein-barr virus prevail in aids-related large cell lymphomas and HIV-negative atypical lymphoproliferations. Blood 86(10):557a (abstract #2214), 1995.
A168. Ramshaw HS, Reddy GPV, Dooner M, Peters SO, Tiarks CY, Quesenberry PJ: Synchronized marrow cells from BALB/c mice exhibit differential engraftment at different points in the cell cycle. Blood 86(10):590a (abstract #2348), 1995.
A169. Cooper CL, Quesenberry PJ: Cytokine-mediated regulation of ID family transcription factors at the differentiation switch point during hematopoietic development. Blood 86(10):661a (abstract #2630), 1995.
A170. Reddy GPV, Ramshaw HS, Tiarks CY, Pang L, Quesenberry PJ: Synchronous progression of hematopoietic stem cells from G1 to S phase in response to cytokines. Blood 86(10):678a (abstract #2701), 1995.
A171. Rothenberger, S, Mitchell T, Bachmann E, McQuain C, Quesenberry PJ, Knecht H: Maximal stimulation of NF-B activity in LMP1 deletion variants from patients with EBV-associated relapsing Hodgkin's disease. Blood 86(10):741a (abstract #2951), 1995.
A172. Patchen ML, Bleicher P, Liang J, Vaudrain T, Maschek B, Jackson JD, Pirrucello A, Kessinger A, Quesenberry PJ: Mobilization of peripheral Blood progenitor cells by Betafectin® PGG-Glucan. (Presented at 25th Annual Meeting of the International Society for Experimental Hematology), 1996.
A173. Al-Homsi AS, Ballen K, Pihan G, Jaswaney V, Quesenberry PJ: Blast cells with cytoplasmic budding and fragmentation. (Presented at ASCO Annual Meeting), 1996.
A174. Ballen KK, Becker PS, KL Lefebvre, Lee KA, Levy W, Butler K, Stewart FM, Quesenberry PJ, Lowry PA: Hyperhydration to prevent hemorrhagic cystitis in bone marow transplant recipients is safe and cost effective. (Presented at IBMTR/ABMTR) 1996.
A175. Ballen KK, Hsieh CC, Levy W, Becker P, Lee K, Butler K, Lefebvre K, Quesenberry PJ, Stewart FM: Who takes care of your bone marrow transplant patients?: A survey of 108 Institutions. Blood 88(10):412a (abstract #1636), 1996.
A176. Ballen KK, Greiner DL, Shultz LK, Hesselton RM, Robinson B, Shearin D, Leif JH, Stewart FM, Quesenberry PJ: Characterization of the proliferative potential of human umbilical cord blood progenitor cells. Blood 88(10):598a (abstract #2381), 1996.
A177. Al-Homsi AS, Ballen KK, Pihan G, Jaswany V, Savarese T, Quesenberry PJ: Unusual case of acute leukemia with intense cytoplasmic fragmentation of blasts: case report and establishment of cell line. Blood 88(10):163b (abstract #3380), 1996.
A178. Ballen KK, Becker PS, Lefebvre KL, Lee KA, Levy W, Butler K, Stewart FM, Quesenberry PJ, Lowry PA: Hyperhydration to prevention hemorrhagic cystitis in bone marrow transplant recipients is safe and cost efective. Blood 88(10):253b (abstract #3738), 1996.
A179. Barranger JA, Rice E, Sansiere C, Bahnson A, Mohney T, Swaney W, Takiyama N, Dunigan J, Beeler M, Lucot S, Schierer-Fochler S, Ball E, Becker PS, Riel GJ, Debatis ME, Quesenberry PJ: Transduction of mobilized CD34⁺ produces marked HPP-CFC: Significance for gene therapy. Exp Hematol 25(8):730 (abstract # 9), 1997.
A180. Berger C, van Baarle D, Kersten MJ, Klein MR, Al-Homsi AS, McQuain C, Quesenberry PJ, van Oers R, Knecht H: Epstein-Barr virsu encoded LMP1 oncogene deletion variants occur and accumulate in lymphocytes during long term HIV-infection. Exp Hematol 25(8):732 (abstract # 15), 1997.
A181. Knecht H, McQuain C, Berger C, Tirnauer JS, Martin J, Janssen R, Odermatt BF, Quesenberry PJ, Potter D: Paradoxical effect of amino terminal LMP1 oncoprotein deletion mutants in NIH-3T3 cells with stable overexpression of calpastatin. Exp Hematol 25(8):776 (abstract # 172), 1997.
A182. Nilsson SK, Dooner MS, Weier HUG, Frenkel B. Lian JB, Stein GS, Quesenberry PJ: Osteoblast progenitors engraft from whole bone marrow transplants in nonablated mice. Exp Hematol 25(8):877 (abstract # 521), 1997.
A183. Stewart FM, Zhong S, Nilsson SK, Quesenberry PJ: Minimal myeloablation of the host increases the competitive dominance of donor stem cells: implication for human gene therapy. Exp Hematol 25(8):892 (abstract # 572), 1997.

A184. Subramanyam YVBK, Prashar Y, Baskaran N, Liu M, Hulspas R, Whitney C, Hoe N, Newburger P, Goguen J, Quesenberry PJ, Weissman SM: Gene Expression in the Heatopoietic System. (Presented at Mini-Sysmposium “Technologies for Differential Gene Expression”, San Francisco, CA, 8/24/97.

A185. Becker PS, Berios V, Nilsson SD, Dooner MS, Banu N, Ramshaw HS, Quesenberry PJ: Stimulatory Cytokines Modulate Adhesion Receptor Expression by Murine Lin-SCA* Cells and Simultaneous Blocking of L, 4, and L-Selectin Inhibits Hematopoietic Progenitor Cell-Stromal Cell Interactions. Blood 90(10):486a (abstract #2160), 1997.
A186. Becker, PS, Riel GJ, Debatis ME, Quesenberry PJ, Rice E, Sansieri C, Bahnson A, Mohney T, Swaney W, Takiyama N, Dunigan J, Beeler M, Lucot S, Schierer-Fochler S, Ball E, Barranger JA: Transfer of the Glucocerebrosidase Gene to CD34* Cells Results in Marking of HPP-CFC. Blood 90(10):237a (abstract # 1043), 1997.
A187. D’Hondt LD, Benoit B, Reilly J, Carlson J, Grimaldi C, Quesenberry PJ: Time Schedule of 5-Fluorouracil Administration and its Influence on Bone Marrow Engraftment Defect into Nonmyeloablated Hosts. Blood 90(10):312b (abstract # 4156), 1997.
A188. Savarese TM, Guardiani R, Campbell C, Zwiezig S, Nelson BE, Quesenberry PJ: Expression of Hematopoietic-Associated Cytokines and Their Receptors in Human Primary Ovarian Tumors. Blood 90(10):164b (abstract # 3459), 1997.
A189. Ballen K, Griener D, Shultz L, Becker P, Leif J, Shearin D, Valinski H, Stewart FM, Quesenberry PJ: Umbilical Cord Blood Demonstrates Tremendous Variability in Cell Counts, Proliferative Potential, and Engraftment in Immunodeficient Mice. Blood 90(10):311b (abstract # 4151), 1997.
A190. Ballen K, Torgersen D, Belcher R, Raymond J, Foster R, Stewart FM, Quesenberry PJ: Molecular Analysis of HLA-A and B Loci In Umbilical Cord Blood Demonstrates Evidence of Non-Correlation with Traditional Serologic Tissue Typing. Blood 90(10):562a (abstract # 2502), 1997.
A191. Ballen K, Raymond J, Fife J, Sroczynski M, Ramos M, Wozniak, K, Shearin D, Ceredona AM, Noller K, Stewart FM, Quesenberry PJ: Who Donates Cord Blood? Blood 90(10):212a (abstract #936), 1997.
A192. Quesenberry PJ, Grimaldi CI, Rao S, Stewart FM: Hematopoietic Stem Cells Cultured in Rotating Bioreactors Show A Defect In Engraftment Capability. Blood 90(10):151b (abstract # 3392), 1997.
A193. Nilsson SK, Dooner MS, Weier H-UG, Frenkel B, Lian JB, Stein GS, Quesenberry PJ: Osteoblast Progenitors Engraft From Whole Bone Marrow Transplants in Nonablated Mice. Blood 90(10):316b (abstract # 4174), 1997.
A194. Nilsson SK, Dooner MS, Quesenberry PJ: Rapid Cell Cycle Induction of Engrafting Long-Term Repopulating Stem Cells. Blood 90(10):94a (abstract # 414), 1997.
A195. Habibian HK, Peters SO, Quesenberry PJ: Fluctuating Engraftment Potential of Cytokine Stimulated Murine Marrows Stem Cells in Liquid Culture. Blood 90(10):145b (abstract # 3365), 1997.
A196. Degar BA, Baskaran N, Hulspas R, Weissman SM, Quesenberry PJ, Forget BG: Identification of a Novel Homeobox Gene mRNA Isoform Expressed in Hematopoietic Stem Cells (HSC). Blood 90(10):305a (abstract # 1351), 1997.
A197. Potter DA, McQuain C, Berger C, Tirnauer JS, Martin J, Janssen R, Odermatt BF, Quesenberry PJ, Knecht H: Paradoxical effect of amino-terminal LMP1 oncoprotein deletion mutants in NIH-3T3 cells with stable overexpression of calpastatin. Blood 90(10):61a (abstract # 268), 1997.
A198. Knecht H, McQuain C, Berger C, Martin J, Esslinger C, Bargou RC, Al-Homsi AS, Drexler HG, Gruss HJ, Quesenberry PJ, Odermatt BF: Reed-Sternberg cells from advanced stage Hodgkin’s disease are refractor to specific inhibition of NF-KB dependent signaling pathways. Blood 90(10):74a (abstract # 321), 1997.
A199. Frimberger AE, Stering AI, Quesenberry PJ: An in vitro model of hematopoietic stem cell homing. Blood 90(10):314b (abstract # 4163), 1997.
A200. Stewart FM, Zhong S, Quesenberry PJ: Effets of minimal irradiation (100 cGy) on donor and/or recipient animals receiving either delayed (six weeks) or immediate bone marrow transplant. Blood 90(10):317b (abstract # 4178), 1997.
A201. Subramanyam YVBK, Prashar Y, Baskaran N, Liu M, Hulspas R, Whitney C, Hoe N, Newburger P, Goguen J, Quesenberry PJ, Weissman SM: Gene expression in the hematopoietic system. Presented - annual mini-sympoisum “Technologies for Differential Gene Expression”, San Francisco, August 1997.
A202. Campbell CL, Savarese DMF, Quesenberry PJ, Savarese TM: Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells. Submitted AACR Annual Meeting - New Orleans, 1998.
A203. Savarese TM, Guardiani R, Campbell C, Mitchell K, Zwiezig BE, Nelson BE, Quesenberry PJ: Expression of cytokines and their receptors in human primary ovarian tumors. Submitted AACR Annual Meeting - New Orleans, 1998.
A204. Becker PS, Riel, GJ, Stewart FM, Forget BG, Barranger JA, Quesenberry PJ: High level engraftment of retrovirally transduced bone marrow cells in minimally myeloablated recipients. Submitted: American Society of Gene Therapy - 1998.
A202. Becker PS, Riel, GJ, Debatis ME, Quesenberry PJ, Rice E, Sansieri C,, Bahnson A, Mohney T, Swaney W, Takiyama N, Dunigan J, Beeler M, Lucot S, Shierer-Fochler S, Ball E, Barranger JA: Transfer of the glucocerebrosidase gene to CD34⁺ cells results in marking of HPP-CFC: Analysis of cell cycle status. Submitted: American Society of Gene Therapy - 1998.
A205. Quesenberry PJ, Grimaldi C, Stewart FM: Differential effect of microgravity conditions on hematopoietic cells depends on rotational speed. Submitted: NASA, 1998.
A206. Grimaldi CI, Tuft RA, Frimberger AE, Quesenberry PJ: High speed optical sectioning fluorescence microscopy in studies of hematolopoietic stem cell biology. ISEH 26(8):639 (abstract # 9), 1998.
A207. Becker PS, Riel GJ, Stewart FM, Forget BG, Barranger JA, Quesenberry PJ: High level engraftment of retrovirally transduced bone marrow cells in minimally myeolablated recipients. ISEH 26(8):640 (abstract # 26), 1998.
A208. Frimberger AE, Stering AI, Bonnici TD, Quesenberry PJ: An in vitro model of hematopietic stem cell homing. ISEH 26(8):643 (abstract # 53), 1998.
A209. Becker PS, Berrios V, Riel GJ, Quesenberry PJ: Functional adhesion of murine Lin^- Sca⁺ and Lin^- Hoechst 33342^LO/rhodamine 123^LO (HO^LORHO^LO) hematopoietic progenitor cells to dexter stroma and extracelular matrix proteins: modulation by cytokines. ISEH 26(8):643 (abstract # 55), 1998.
A210. D’Hondt L, Benoit B, Carlson J, Reilly J, Quesenberry PJ: Influence of time schduled 5-fluorouracil (5-FU) administration on bone marrow engraftment defect into nonmyeloablated hosts. ISEH 26(8):660 (abstract # 261), 1998.
A211. D’Hondt L, Benoit B, Carlson J, Reilly J, Quesenberry PJ: Low dose irradiation (100 cGy) allows high levels of engraftment and precise analysis of engraftment defect induced by 5-fluorouracil administration. ISEH 26(8):660 (abstract # 262), 1998.
A212. Stewart FM, Zhong S, Quesenberry PJ: Effects of minimal irradiation (100 cGy) on donor and/or recipient animals receiving either delayed (six weeks) or immediate bone marrow transplant. ISEH 26(8):660 (abstract # 263), 1998.
A213. Quesenberry PJ, Zhong S, Ballen KK, Emmons R, Skare J, Rosohansky S, FitzGerald TJ, Levy W, Al-Homsi SA, Hsieh HH, Stein G, Szymanski I, Butler K, Becker PS, Stewart FM: Allochimserism in mouse and man. Blood 92(10):262a (abstract # 1075), 1998.
A214. Frimberger AE, Moore AS, Cotter SM, Rassnick KM, Williams LE, Kristal O, Northrup NC, London CA, Quesenberry PJ: Submyeloablative escalated chemotherapy with autologous bone marrow support in a dog lymphoma model. Blood 92(10):264a (abstract # 1085), 1998.
A215. Riel GJ, Debatis ME, Forget BG, Barker JE, Stewart FM, Quesenberry PJ, Becker PS: Retroviral mediated transfer of a hybrid moiuse/human erythroid ankyrin minigene to bone marrow progenitors: engraftment in minimally myeloablated recipients. Blood 92(10):298a (abstract # 1219), 1998.
A216. Becker PS, Riel GJ, Barranger JA, Stewart FM, Quesenberry PJ: Infusion of glucocerebrosidase (GC) transduced murine bone marrow progenitors results in high level engraftment of minimally meyloablated recipients. Blood 92(10):298a (abstract # 1221), 1998.
A217. Quesenberry PJ, Reddy PV, McAuliffe CI, Pang L, Stewart FM, Becker PS, Bertoncello I: Cel cycle phenotype of cytokine stimulated lineage negative Hoechst low rhodamine low – effluxed stem cells. Blood 92(10):373a (abstract # 1537), 1998.
A218. D’Hondt L, Damon J, Cerny J, Carlson J, Reilly J, Quesenberry PJ: High levels of Bone Marrow (BM) engraftment when 5-Fluorouracil (5-FU) treated marrow is transplanted into submyeloablated hosts. Blood 92(10):373a (abstract # 1538), 1998.
A219. Knecht H, McQuain C, Berger C, Rothenberger S, Martin J, Esslinger C, Drexler HG, Cai YC, Quesenberry PJ, Odermatt BF: Latent membrane protein 1 associated signaling pathways are important in tumor cells of epstein-barr virus negative Hodgkin’s disease. Blood 92(10):407a (abstract # 1680), 1998.
A220. Hurlbut P, Challies T, Berrios V, Riel GJ, Ballen KK, Quesenberry PJ, Becker PS: Modulation of adhesion receptor expression on CD34+ cells by expansion cytokines: IL-3, IL-6, SCF vs IL-3, IL-6, SCF, TPO, FLT3/FLK2. Blood 92(10):439a (abstract # 1818), 1998.
A221. Degar BA, Krause DS, Baskaran N, Hulspas R, Quesenberry PJ, Weissman SM, Forget BG: The homeobox gene Pitx2 is expressed in hematopoietic stem/progenitor cells but not in their differentiated progeny. Blood 92(10):574a (abstract # 2362), 1998.
A222. Liu M, Baskaran N, Hulspas R, Quesenberry PJ, Berliner N, Perkins AS, Forget BG, Weissman SM: Characterization of gene expression pattern in mouse hematopoietic stem cells. Blood 92(10):574a (abstract # 2364), 1998.
A223. McAuliffe CI, Tuft RA, Frimberger AE, Quesenberry PJ: Digital imaging microscoy in studies of hematop9ietic stem cell movements and cellular association. Blood 92(10):583a (abstract # 2403), 1998.
A224. Becker PS, Berrios V, Riel GJ, Quesenberry PJ: Adhesion receptors critical to the interaction of murine stem cells with exter stroma and extracellular matrix (ECM) proteins: modulation of receptor expression by preincubation of Lin^- Hoechst 33342 ^LO/rhodamine 123^LO cells with ECM. Blood 92(10):585a (abstract # 2409), 1998.
A225. Frimberger AE, Stering AI, Tuft RA, McAuliffe CI, Becker PS, Berrios VM, Bonnici TD, Quesenberry PJ: An in vitro model of hematopoietic stem cell homing. Blood 92(10):585a (abstract # 2410), 1998.
A226. Becker PS, Berrios V, Gold J, Barretti M, Scavone M, ballen KK, Stewart FM, Quesenberry PJ, Hsieh CC: Adhesion receptor expression on CD34+ cells from peripheral blood or bone marrow grafts: correlation with time toengraftment. Blood 92(10):722a (abstract # 2966), 1998.
A227. McAuliffe CI, Colvin G, Rao S, Reilly J, Stewart FM, Quesenberry PJ: Studies of engraftable hematopoietic stem cells cultured under simulated microgravity. Blood 92(10):726a (abstract # 2978), 1998.
A228. Gordon J. Quesenberry PJ: Hematology consultation in the intensive care unit setting. Blood 92(10):84b (abstract # 3344), 1998.
A229. Benoit BO, Joly M, Engstrom CE, Reilly J, Quesenberry PJ: Neurotrophin channeling of neuroprogenitor differentiation. Blood 92(10):141b (abstract # 3579), 1998.
A230. Joly M, Benoit B, Engstrom CE, Quesenberry PJ: The neuroprogenitor system. Blood 92(10):145b (abstract # 3596), 1998.
A231. Becker PS, O’Donnell J, Sarcinelli F, Pechet L, Taplin M, Walsh W, Stewart FM, Quesenberry PJ: GM-CSF with successive concomitant therapy with low dose ARA-C for older patients with advanced myelodysplastic syndrome (MDS), secondary or refractory acute myeloid leukemia (AML). Blood 92(10):215b (abstract # 3922), 1998.
A232. D’Hondt L, Damon J, Cerny J, Carlson J, Reilly J, Quesenberry PJ: Circadian engraftment variability of normal or 5-fluorouracil (5-FU) treated bone marrow into nonmyeloablated hosts. Blood 92(10):285b (abstract # 4231), 1998.
A233. Stewart FM, Zhong S, Quesenberry PJ, Szymanski I: Effects of irradiation (100 cGy) on donor and/or recipient animals receiving either delayed or immediate bone marrow transplant. Blood 92(10):289b (abstract # 4246), 1998.
A234. Nelson C, Quesenberry PJ, Savarese T: Co-expression of IL-11 and IL-11 receptor (IL-11Ra) in primary neoplasms (ovarian) and cultured cell lines. Submited AACR meeting, 1999.
A235. Quesenberry PJ, Zhong S, Wang H, Werme K, Zuypers F, Lubin BH, Watson G: Creation of chimerism in a thalassemic mouse model. Presented American Pediatric Society & The Soceity for Pediatric Research, 1999.
A236. Campbell CL, Nelson B, Quesenberry PJ, Savarese TM: Coexpression of IL-11 and IL-11 receptor (IL-11R) in primary neoplasms (ovarian) and cultured cell lines. Submitted American Academy of Cancer Research, 1999.
A237. Levy W, Barretti M, Becker PS, Butler K, Emmons R, Doyle P, Quesenberry PJ, Stewart FM, Ballen KK. High dose cyclophosphamide, carmustine, and etoposide for non-hodgkin’s lymphoma is a safe and effective conditioning regimen for allogeneic progenitor cell transplant. Submitted American Society of Clinical Oncology, 1999.
A238. Berrios VM, Dooner GJ, Quesenberry PJ, Becker PS. Cytokine incubation (IL-3, IL-6, IL-11, SCF) dramaticaly alters adhesion receptor expression by murine Lin^- Hoechst 33342^LO/rhodamine^LO hematopoietic stem cells. Submitted American Society of Gene Therapy, 1999.
A239. Pang L, Reddy PV, Quesenberry PJ. Are bone marrow stem cells quiescent? Submitted International Society for Experimental Hematology, 1999.
A240. Frimberger AE, McAuliffe CI, Tuft RA, Quesenberry PJ. Studies of hematopoietic stem cell movement and membrane protrusions. Submitted International Society for Experimental Hematology, 1999.
A241. D’Hondt L, Carlson J, Reilly J, Quesenberry PJ. Concomittant number decrease and cell cycle induction of high proliferative potential colony-forming cells (HPP-CFC) after 5-fluorouracil (5-FU) administration in BALB/c mice. Submitted American Associate for Cancer Research, 1999.
A242. Berrios VM, Dooner GJ, Quesenberry PJ, Becker PS. Treatment with stimulatory cytokines dramatically alters adhesion receptor expression by murine Lin^- Hoescht 33342^LO/rhodamine 123^LO hematopoietic stem cells. Submitted International Society for Experimental Hematology, 1999.
A243. Becker PS, Berrios VM, Gold J, Baretti M, Scavone M, Ballen KK, Stewart FM, Quesenberry PJ, Hsieh CC. Adhesion receptor expresion on CD34⁺ cells from peripheral blood or bone marrow grafts: correlation with time to engraftment. Submitted International Society for Experimental Hematology, 1999.
A244. Berrios V, Riel G, Ballen KK, Quesenberry PJ, Becker PS. Modulation of adhesionreceptor expression on CD34⁺ cells by expansion cytokines: IL-3, IL-6, SCF VS. IL-3, IL-6 SCF, TPO, FLT3/FLK2. Submitted International Society for Experimental Hematology, 1999.
A245. Benoit BO, Savarese T, Joly M, Engstrom CM, Reilly J, Hulspas R, Recht L, Quesenberry PJ. Neurotrophin channeling of neuroprogenitor differentiation. Submitted Society for Neuroscience, 1999.
A246. Lambert JF, Benoit BO, Colvin GA, Carlson J, Delville Y, Schwartz WJ, Quesenberry PJ. Quick sex determination of mouse fetuses. Submitted Society for Neuroscience, 1999.
A247. Engstrom CM, Joly M, Benoit BO, Hulspas R, Savarese T, Recht L, Quesenberry PJ. Single cell cloning and characteristics of EGF-responsive neural progenitor cells. Submitted Society for Neuroscience, 1999.
A248. Delville Y, Benoit BO, Lambert JF, Quesenberry PJ. Sexual differentiation of neural stem cells in culture. Submitted Society for Neuroscience, 1999.
A249. Ross AH, Lachyankar MB, Sultana N, Schonhoff CM, Mitra P, Poluha W, Lambert S, Quesenberry PJ, Litofsky NS, Nabi R, Recht LD. A role for PTEN in neuronal diferentiation. Submitted Society for Neuroscience, 1999.
A250. Colvin GA, Lambert JF, Carlson JE, Quesenberry PJ: Regional Distribution of Marrow Cells and Progenitors. Submitted to ASH, 2000.
A251. Frimberger AE, Moore AS, Rassnick KM, Northrup NC, Kristal O, Chretin JD, Quesenberry PJ: Effect of marrow infusion schedule in autologous bone marrow support for submyeloablative chemotherapy dose intensification in canine lymphoma. Submitted to ASH, 2000.
A252. McAuliffe C, Dooner M, Werme K, Quesenberry PJ: Temporal domains of the engraftable stem cell. Submitted to ASH, 2000.
A253. Dooner MS, Cerny J, Becker P, Quesenberry PJ: Cytokine treatment of hematopoietic stem/progenitor cells induces a homing defect in nonmyeloablated hosts. Submitted to ASH, 2000.
A254. Lambert JF, Colvin GA, Carlson JE, Cerny J, Quesenberry PJ: allogeneic homing of bone marrow and purified stem cells using direct or surrogate approaches. Submitted to ASH, 2000.
A255. Rossi HA, O’Donnell J, Sarcinelli F, Stewart FM, Quesenberry PJ, Becker PS: GM-CSF priming with successive concomitant therapy with low dose ARA-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome. Submitted to ASH, 2000.
A256. Zhong S, Wang H, Stewart FM, Quesenberry PJ: Murine allochimerism in nonirradiated H2-mismatched transplants with anti-CD40 ligand blockade. Submitted to ASH, 2000.
A257. Ballen K, Becker P, Emmons R, Fitzgerald T, Hsieh C, Liu Q, Heyes C, Chiafari F, Szymanski I, Rososhansky S, Stewart F, Quesenberry PJ: Low dose radiation and allogeneic lymphocyte infusion induce complete remission in refractory cancer patients. Submitted to ASH, 2000.
A258. Nowakowshi GS, Dooner M, Berrios V, Valinski H, Quesenberry PJ, Becker PS: A bone marrow stem cell homing heptapeptide from a phage display library reduces bone marrow homing after transplantation. Submitted to ASH, 2000.
A259. Ballen K, Becker P, Emmons R, Fitzgerald T, Hsieh C, Liu Q, Heyes C, Chiafari F, Szymanski I, Rososhansky S, Stewart F, Quesenberry PJ: Donor engraftment can be achieved with low CD34 dose in minimyeloablative transplants: A stem cell competition effect? Submitted to ASH, 2000.
A260. Miller CE, Quesenberry PJ: Cell Cycle related plasticity of differentiation in Lin- Rho low Ho low stem cells. Submitted to ASH, 2000.
A261. Becker PS, Dooner G, Valinski H, Kopp D, Novelli E, Swandy W, Liu Q, Hsieh CC, Quesenberry PJ, Barranger JA: Cell cycle status of primitive colony forming cells infused in patients undergoing gene therapy for Gaucher Disease. Submitted to ASH, 2000.
A262. Almeida-Porada G, Crapnell K, Porada C, Benoit B, Nakauchi H, Quesenberry PJ, Zanjani ED: In vivo hematopoietic potential of human neuronal stem cells. Submitted to ISEH, 2000.
A263. Cerny J, Dooner MS, Quesenberry PJ: Cytokine treatment of hematopoietic stem/progenitor cells induces a homing defect in nonmyeloablated hosts. Submitted to ISEH, 2000.
A264. Lambert JF, Colvin GA, Carlson JE, Cerny J, Quesenberry PJ: In vivo allogeneic homing using CFSE labeled murine stem cells or surrogate secondary transplant. Submitted to ISEH, 2000.
A265. Frimberger AE, Moore AS, Quesenberry PJ: Autologous bone marrow support for submyeloablative chemotherapy dose intensification in canine lymphoma. Submitted to ISEH, 2000.
A266. Benoit BO, Savarese T, Joly M, Engstrom CM, Reilly J, Recht L, Quesenberry PJ: Neurotrophin channeling of neuroprogenitor differentiation. Submitted to ISEH, 2000.
A267. Damon J, D’Hondt L, Reilly J, Grimaldi C, Carlson J, Wuu J, Dooner M, Benoit S, Colvin G, Quesenberry PJ: Definitive evidence for the influence of circadian rhythm on bone marrow (BM) stem cell engraftability. Submitted to ISEH, 2000.
A268. Miller C, Reilly J, Quesenberry PJ: Reversible differentiation in Lin- Rho^lo Ho^lo cultured stem cells. Submitted to ISEH, 2000.
A269. Colvin GA, Carlson JE, Lambert JF, McAuliffe CI, Quesenberry PJ: Hematopoietic stem cells in microgravity. Submitted to ISEH, 2000.
A270. Abedi M, Colvin GA, Lambert JF, Dooner M, McAuliffe CI, Miller C, Quesenberry PJ: Tolerance induction by costimulator blockade in 100cGy treated hosts with varying degrees of generic disparity. Submitted to ASH, 2001.
A271. Colvin GA, Lambert JF, Abedi M, Quesenberry PJ: Geographic and quantitative determinants in stem cell biology favor a competitive replacement model of engraftment. Submitted to ASH, 2001.
A272. Abedi M, Lambert JF, Colvin GA, Dooner MS, McAuliffe CI, Miller C, Quesenberry PJ: Transplantation with costimulation blockade and low dose radiation inhibit the generation of a graft-versus-leukemia effect. Submitted to ASH, 2001.
A273. Jani CR, Ballen KK, Emmons R, Ford PA, Stewart FM, Quesenberry PJ, Otway LA, Levy WS, Becker PS: High dose chemotherapy and autologous stem cell transplant without blood product support: “bloodless transplantation”. Submitted to ASH, 2001.
A274. Colvin GA, Lambert JF, Carlson JA, Quesenberry PJ: Total cellularity of murine marrow and the concept of marrow stem cell competition. Submitted to ISEH, 2001.
A275. Frimberger AE, Moore AS, Quesenberry PJ: Kinetically timed, primed marrow support for high-dose chemotherapy in canine lymphoma patients. Submitted to ISEH, 2001.
A276. Lambert JF, Colvin GA, Zhong S, Stewart FM, Quesenberry PJ: Mini-chimerism and repetitive transplant allows tolerization with CD40 ligand blockade alone. Submitted to ISEH, 2001.
A277. Colvin GA, Lambert JF, Lum LG, Rathore R, Falvey M, Kouttab N, Abedi M, Quesenberry PJ, Elfenbein GJ: The haplo-immunostorm syndrome: A new clinical entity observed in minimal immunotherapy with outpatient haploidentical bone marrow transplantation. Submitted to ASH, 2002.
A278 Colvin GA, Lambert JF, Abedi M, McAuliffe CI, Quesenberry PJ: Stem/progenitor cell inversions: The chiaroscuro stem cell continuum model of hematopoiesis. Submitted to ASH, 2002.
A279. Abedi M, Greer DA, Colvin GA, Lambert JF, Demers DA, Moore BE, McAuliffe CI, Dooner M, Quesenberry PJ: Importance of injury in transdifferentiation of bone marrow to liver cells. Submitted to ASH, 2002.
A280. Abedi M, Greer DA, Badiavas E, Demers DA, Colvin GA, Lambert JF, Falanga V, Quesenberry PJ: Transdifferentiation of bone marrow cells in a skin injury model. Submitted to ASH, 2002.
A281. Colvin GA, Lambert JF, Lum LG, Rathore R, Falvey M, Abedi M, Quesenberry PJ, Elfenbein GJ: Effective universal outpatient immunotherapeutic approach for refractory acute myelocytic leukemia: HLA-haploidentical transplants in 100cGy-conditioned hosts. Submitted to ASH, 2002.
A282. Rathore R, Colvin GA, Kouttab NM, Falvey MT, Grabert RC, Smith JA, Tiggs JC, Cohen SI, Maizel AL, Quesenberry PJ, Elfenbein GJ, Lum LG: Activated T cells armed with anti-CD3 x anti-HER2/neu Bispecific antibody III. Kinetics and survival of armed ATC in prostate cancer patients. Submitted to ASH, 2002.
A283. Lambert JF, Liu M, Colvin GA, Forget BG, Weissman SM, Quesenberry PJ: Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. Submitted to ASH, 2002.
A284. Abedi M, Badiavas E, Lambert JF, Colvin G, Falanga V, Quesenberry PJ: Trafficking and transdifferentiation of bone marrow cells in a skin injury model. Submitted to ISEH, 2002.
A285. Colvin G, Lambert JF, Lum L, Rathore R, Quesenberry PJ, Elfenbein G: Universal immunotherapeutic approach for patients with refractory malignancies: HLA-haploidentical transplants in 100 cGy-conditioned hosts. Submitted to ISEH, 2002.
A286. Lambert JF, Liu M, Baskaran NV, Colvin G, McAuliffe CI, Forget BG, Weissman SM, Quesenberry PJ: Purified hematopoietic stem cells show a major shift of gene expression through cell cycle that coincides with an engraftment nadir. Submitted to ISEH, 2002.
A287. Colvin G, Lambert JF, McAuliffe C, Quesenberry PJ: Stem/progenitor cell inversions: The chiaroscuro stem cell model of hematopoiesis. Submitted to ISEH, 2002.
A288. Abedi M, Colvin G, Lambert JF, McAuliffe C, Dooner M, Quesenberry PJ: Green fluorescent protein (GFP) positive marrow trafficking to injured murine liver. Submitted to ISEH, 2002.
A289. Lambert JF, Colvin G, Carlson J, Quesenberry PJ: Marked regional stem/progenitor cell distribution differences within different marrow compartments. Submitted to ISEH, 2002.
A290. Quesenberry PJ: The new stem cell biology: Clinical implications. Submitted to ISEH, 2002.
A291. Abedi M, Greer DA, Colvin GA, Dooner MS, Demers DA, Quesenberry PJ: Robust conversion of marrow cells to skeletal muscle with formation of marrow derived muscle cell colonies: A multifactorial process. Submitted to ASH, 2003.
A292. Dooner MS, Pimentel J, Cerny J, Colvin GA, Abedi M, Demers D, Greer D, Quesenberry PJ: Directed engraftment and homing of whole bone marrow and stem cells to lung. Submitted to ASH, 2003.
A293. Sun A, Boden D, Ramratnam B, Quesenberry PJ, Rosmarin A: Inhibition of PU.1 expression by RNA interference. Submitted to ASH, 2003.
A294. Mogi M, Quesenberry PJ, Walsh K: Akt-signaling regulates side-population cell phenotype via Bcrp1 translocation. Submitted to ASH, 2003.
A295. Colvin GA, Dooner M, Abedi M, Demers D, Lambert JF, Quesenberry PJ: Differentiation profiling of cycling murine marrow stem cells: Identification of megakaryocyte and granulocyte differentiation “hotspots”. Submitted to ASH, 2003.
A296. Cerny J, Demers D, Dooner MS, Memon MK, Pimentel J, Colvin GA, Abedi M, Greer D, Quesenberry PJ: Unveiling the molecular signature of a lung homing “hotspot” of hematopoietic stem cells with phagemid display: implications for tissue conversions. Submitted to ASH, 2003.
A297. Colvin G, Dooner M, Lambert JF, Demers D, Abedi M, Quesenberry PJ: Dramatic cell cycle progenitor expression shifts through cell cycle. Submitted to ISEH, 2003.
A298. Elfenbein G, Lum L, Rathore R, Colvin G, Abedi M, Quesenberry PJ, Morgan D, Falvey M: Engraftment potential of marrow harvested after chemo-growth factor mobilized blood collection. Submitted to ISEH, 2003.
A299. Abedi M, Greer D, Demers D, Colvin G, Dooner M, Cerny J, Moore B, Quesenberry PJ: Bone marrow cells participate in regeneration of skeletal muscle by transdifferentiation to muscle cells. Submitted to ISEH, 2003.
A300. Cerny J, Dooner M, Demers D, Pimentel J, McAuliffe C, Parent A, Greer D, Quesenberry PJ: A cell cycle related lung homing “hotspot”. Submitted to ISEH, 2003.
A301 Colvin GA, Abedi M, Rathore R, Lum LG, Ballen KK, Dey B, Elfenbein GJ, Quesenberry PJ: Mini-haploidentical transplantation for refractory acute myeloid leukemia. Submitted to ASH, 2004.
A302. Abedi M, Greer DA, Foster BA, Colvin GA, Harpel JA, Dooner MS, Quesenberry PJ: Importance of transplantation variables in marrow to muscle conversion. Submitted to ASH, 2004.
A303. Abedi M, Greer DA, Foster BA, Demers DA, Colvin GA, Dooner MS, Quesenberry PJ: Marrow derived muscle colonies are a clonal phenomenon. Submitted to ASH, 2004.
A304. Colvin GA, Dooner MS, Abedi M, Quesenberry PJ: The heterogeneity of clonally derived purified murine marrow stem cell colonies. Submitted to ASH, 2004.
A305 Dooner GJ, Colvin GA, Dooner MS, Quesenberry PJ: Cell cycle related stem cell gene expression. Submitted to ASH, 2004.
A306. Aliotta JM, Abedi M, Colvin G, Demers D, Dooner MS, Greer D, Pimentel J, Quesenberry PJ: Conversion of whole bone marrow cells to cells of the lung after radiation and cardiotoxin injuries. Submitted to ISEH, 2004.
A307. Abedi M, Greer DA, Foster BM, Colvin GA, Dooner MS, Dooner GJ, Demers DA, Pimentel J, Quesenberry PJ: Demonstration of colony forming unit muscle (CFU-M). Submitted to ISEH, 2004.
A308. Abedi M, Greer DA, Foster BM, Colvin GA, Dooner MS, Dooner GJ, Demers DA, Pimentel J, Quesenberry PJ: Kinetics of transplantation and injury are critical in the incidence of marrow to muscle conversion. Submitted to ISEH, 2004.
A309. Colvin GA, Dooner MS, Abedi M, Demers D, Aliotta J, Ramanathan M, Huerta F, Bitar I, Lambert JF, Quesenberry PJ: Hotspots of differentiation found in clonally derived purified murine marrow stem cells. Submitted to ISEH, 2004.
A310. Colvin GA, Lambert JF, Lum LG, Abedi M, Rathore R, Falvey M, Ballen KK, Novitsky N, Elfenbein GE, Quesenberry PJ: Outpatient HLA-haploidentical transplants for refractory acute myeloid leukemia. Submitted to ISEH, 2004.
A311 Dooner MS, Paggioli D, Hebert H, Pimentel J, Abedi M, Greer D, Quesenberry PJ: Proteopod formation and sequestering of whole bone marrow cells by bone marrow stromal cells in vitro. Submitted to ISEH, 2004.
A312. Colvin GA, Dooner MS, Abedi M, Demers D, Aliotta J, Huerta F, Ramanathan M, Bitar I, Lambert JF, Quesenberry PJ: Pronounced heterogeneity of clonally derived purified murine marrow stem cells. Submitted to ISEH, 2004.
A313. Pimentel J, Dooner MS, McAuliffe C, Demers D, Yoshikawa T, Menaker M, Quesenberry PJ: Circadian rhythms of isolated populations of PER1-LUC transgenic bone marrow. Submitted to ISEH, 2004.
A314. Colvin GA, Lambert JF, Lum LG, Rathore R, Abedi M, Ballen KK, Novitsky N, Falvey M, Elfenbein GE, Quesenberry PJ: The haploimmunostorm syndrome: A clinical entity observed in mini-haploidentical bone marrow transplantation. Submitted to ISEH, 2004.
A315. Cerny J, Dooner MS, Demers D, Pimentel J, Menon MK, Colvin GA, Abedi M, Greer D, Quesenberry PJ: Molecular characterization of lung homing hematopoietic stem cell microenvironment using phagemid display. Submitted to ISEH, 2004.
A316. Dooner M, Pimentel J, Colvin G, Abedi M, Aliotta J, Demers D, Greer D, Dooner G, Cerny J, Quesenberry PJ: Engraftment and homing of whole bone marrow and stem cells to lung. Submitted to ISEH, 2004.
A317. Greer DA, Abedi M, Dooner MS, Quesenberry PJ: A double label system for donor cell identification. Submitted to ISEH, 2004.
A318. Badiavas EV, Kouttab N, Quesenberry PJ: Expression of cytokeratin in lineage negative bone marrow cells placed in co-culture with skin fibroblasts. Submitted to ISEH, 2004.
A319. Colvin GA, Dooner MS, Abedi M, Quesenberry PJ: The heterogeneity of clonally derived purified murine marrow stem cell colonies. Submitted to ASH, 2004.
A320. Abedi M, Greer DA, Foster BA, Colvin GA, Harpel JA, Dooner MS, Quesenberry PJ: Importance of transplantation variables in marrow to muscle conversion. Submitted to ASH, 2004.
A321. Abedi M, Greer DA, Foster BA, Demers DA, Colvin GA, Dooner MS, Quesenberry PJ: Marrow derived muscle colonies are a clonal phenomenon. Submitted to ASH, 2004.
A322. Colvin GA, Abedi M, Rathore R, Lum LG, Ballen KK, Dey B, Elfenbein GJ, Quesenberry PJ: Mini-haploidentical transplantation for refractory acute myeloid leukemia. Submitted to ASH, 2004.
A323. Colvin GA, Dooner G, Demers D, Pascual S, Chung S, Dooner MS, Abedi M, Quesenberry PJ: Differentiation profiling of marrow stem cells: a megakaryopoietic hotspot and the continuum model of hematopoiesis. Submitted to ASH, 2005.
A324. Abedi M, Greer DA, Foster BM, Colvin GA, Demers DA, Dooner MS, Quesenberry PJ: Highly purified hematopoietic stem cells convert to cells with myoblast characteristics before forming myotubes. Submitted to ASH, 2005.
A325. Abedi M, Greer DA, Foster BA, Demers DA, Colvin GA, Dooner MS, Quesenberry PJ: Highly purified hematopoietic stem cell population is responsible for marrow to muscle conversion. Submitted to ISEH, 2005.
A326. Abedi M, Foster BM, Greer DA, Colvin GA, Demers DA, Dooner MS, Peterson A, Quesenberry PJ: Homing of marrow cells to skeletal muscle results in a novel population of cells that can participate in muscle regeneration. Submitted to ISEH, 2005.
A327. Dooner GJ, Dooner MS, Colvin GA, Quesenberry PJ: Lin-Sca+ sorted murine bone marrow: fluctuations in phenotype expression through cell cycle. Submitted to ISEH, 2005.
A328. Greer D, Peterson A, Demers DA, Dooner MS, Foster BM, Colvin GA, Sanchez-Guijo FM, Pimentel J, Milani C, Quesenberry PJ, Abedi M: Phage directed homing inhibition in skeletal muscle. Submitted to ISEH, 2005.
A329. Aliotta JM, Keaney P, Passero M, Dooner MS, Pimentel J, Colvin GA, Abedi M, Demers DA, Greer DA, Quesenberry PJ: Bone marrow mobilization with G-CSF and transplantation with certain stem cell subpopulations influence lung cell production in radiation-injured mice. Submitted to ISEH, 2005.
A330. Peterson AL, Dooner MS, Quesenberry PJ: Stem cell-stromal cell interactions: observations from time lapse photography experiments. Submitted to ISEH, 2005.
A331. Dooner M, Yoshikawa T, Demers D, Pimentel J, Dooner G, Menaker M, Quesenberry PJ: Prolonged and durable circadian rhythms of isolated populations of PER1-LUC and PER2-LUC transgenic bone marrow. Submitted to ISEH, 2005.
A332. Quesenberry PJ, Del Tatto M, Berz D, Miner T, Ng T, Winer ES, Aliotta J, Colvin G, Dooner M, Dooner G, Fontaine JP: Marrow cell genetic phenotype change induced by human lung cancer cells. Submitted to ASCO, 2009.
A333. Quesenberry PJ, Aliotta J, Dooner M, Johnson K, Ramratnam B: Population Based Model of Marrow Stem Cell Biology. Submitted to ISSCR Annual Meeting, 2010.
A334 Del Tatto M, Ng T, Aliotta J, Colvin G, Dooner M, Berz D, Dooner G, Bassam A, Papa E, Quesenberry PJ: Human Marrow Cell Genetic Phenotype Induced by Human Cancers Involving The Lung. Submitted to ISSCR Annual Meeting, 2010.
A335 Aliotta J, Pereira M, Dooner M, Quesenberry PJ: Microvesicle Modulation of Cell Phenotype. Submitted to ISSCR Annual Meeting, 2010.
A336 Dooner M, Renzulli II, Del Tatto, M, Dooner G, Mega A, Goldstein L, Colvin G, Quesenberry PJ: Microvesicle Mediated Expression of Human Prostate Specific Gene Expression in Co-Cultured Normal Human Bone Marrow Cells. Submitted to ISSCR Annual Meeting, 2010.
A337 Pereira M, Aliotta J, Dooner M, Del Tatto M, Quesenberry PJ: Persistence of Microvesicle-Induced Gene Expression Changes in Murine Marrow Cells Using an In Vitro and and In Vivo Model. Submitted to ISSCR Annual Meeting, 2010.

SCHOLARLY WORK PUBLISHED IN OTHER MEDIA

Peer-Reviewed – as noted above

Non-Peer-Reviewed – as noted above
INVITED PRESENTATIONS